Document is current
Any future updates will be listed below
-
Authors
Wang, Liqin https://orcid.org/0000-0002-9881-6432
Jin, Haojie
Jochems, Fleur https://orcid.org/0000-0001-7305-7321
Wang, Siying
Lieftink, Cor
Martinez, Isabel Mora https://orcid.org/0000-0002-1033-2784
De Conti, Giulia https://orcid.org/0000-0002-2647-228X
Edwards, Finn
de Oliveira, Rodrigo Leite https://orcid.org/0000-0002-9696-2014
Schepers, Arnout
Zhou, Yangyang https://orcid.org/0000-0002-2964-2803
Zheng, Jiaojiao
Wu, Wei
Zheng, Xingling
Yuan, Shengxian
Ling, Jing
Jastrzebski, Kathy https://orcid.org/0000-0002-3062-9016
Santos Dias, Matheus Dos
Song, Ji-Ying
Celie, Patrick N. H.
Yagita, Hideo
Yao, Ming
Zhou, Weiping https://orcid.org/0000-0002-8464-3454
Beijersbergen, Roderick L. https://orcid.org/0000-0003-0116-4130
Qin, Wenxin https://orcid.org/0000-0002-1989-3027
Bernards, René https://orcid.org/0000-0001-8677-3423
- License Information
-
More Information
Article History
Received: 19 May 2022
Accepted: 12 October 2022
First Online: 22 November 2022
Competing interests
: L.W. and R.B. are named inventors on a patent application based on the study (owned by the Netherlands Cancer Institute). L.W. and R.B. are current part-time employees of Oncosence. R.B. is shareholder of Oncosence. R.B. is the board member of LIXTE Biotechnology. The remaining authors declare no competing interests.
